Pietri A, Dunn F L, Raskin P
Diabetes. 1980 Dec;29(12):1001-5. doi: 10.2337/diab.29.12.1001.
We studied short-term changes in plasma lipid levels in type I diabetics treated with either a conventional insulin regimen or continuous subcutaneous insulin infusion. Mean plasma glucose dropped from 260 +/- 18 to 134 +/- 8 mg/dl when conventional treatment was used and from 194 +/- 18 to 108 +/- 8 mg/dl with CSII. Both forms of therapy were associated with a significant fall in plasma triglyceride levels. However, only CSII treatment produced significant changes in total plasma cholesterol and LDL cholesterol levels. Total cholesterol fell from 195 +/- 17 mg/dl to 161 +/- 11 mg/dl and LDL cholesterol fell from 129 +/- 13 mg/dl to 102 +/- 9 mg/dl. We conclude that improved diabetic control by any method is effective in lowering plasma triglyceride levels, but it requires almost perfect metabolic control to affect plasma cholesterol and LDL cholesterol levels. The changes in plasma lipid and lipoprotein achieved with CSII may favorably alter the prediction for the development of premature atherosclerosis in our patients.
我们研究了接受传统胰岛素治疗方案或持续皮下胰岛素输注治疗的I型糖尿病患者血浆脂质水平的短期变化。采用传统治疗时,平均血浆葡萄糖水平从260±18降至134±8mg/dl,采用持续皮下胰岛素输注(CSII)时从194±18降至108±8mg/dl。两种治疗方式均与血浆甘油三酯水平显著下降有关。然而,只有CSII治疗使总血浆胆固醇和低密度脂蛋白胆固醇水平发生了显著变化。总胆固醇从195±17mg/dl降至161±11mg/dl,低密度脂蛋白胆固醇从129±13mg/dl降至102±9mg/dl。我们得出结论,通过任何方法改善糖尿病控制都能有效降低血浆甘油三酯水平,但要影响血浆胆固醇和低密度脂蛋白胆固醇水平则需要近乎完美的代谢控制。CSII实现的血浆脂质和脂蛋白变化可能会有利地改变我们患者过早发生动脉粥样硬化的预测。